pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,231 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT783Endpoints585BioPharma Dive224onclive165BioSpace59Fierce Biotech57raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • STAT+: Up and down the ladder: The latest comings and goings
    From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
    STAT · 1mo ago↗ source
  • Opinion: Maternity deserts aren’t accidents. They’re the result of a design flaw
    Shrinking fertility should mean less strain on doctors. But nearly half of U.S. counties lack a practicing obstetrician or gynecologist.
    STAT · 1mo ago↗ source
  • Opinion: STAT+: The real work for making dramatic gains against pancreatic cancer is just beginning
    The co-founders of Darwin Health write that the real work for making dramatic gains against pancreatic cancers is just beginning.
    STAT
← prev
page 17 of 50
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
· 1mo ago
↗ source
  • Tennessee pharmacies sell potent ivermectin, led by anti-vaccine doctor who’s taken ‘bucketloads’
    Tennessee pharmacies are selling potent versions of the antiparasitic drug ivermectin, led by an anti-vaccine doctor who’s taken "bucketloads."
    STAT · 1mo ago↗ source
  • Federal grant delays could jeopardize essential disability services, research
    Disability researchers across the country worry about their jobs, and the future of their institutions, as a delay in issuing federal grants drags on.
    STAT · 1mo ago↗ source
  • STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program
    Medicare Advantage plans that receive four out of five stars or better get bonus payments, which have ballooned to $16 billion this year.
    STAT · 1mo ago↗ source
  • STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
    A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.
    STAT · 1mo ago↗ source
  • Moderna flu vaccine wins unanimous support from FDA panel
    <figure><div><img src="https://imgproxy.divecdn.com/CkUxnyfQm3Zx49okGV82WTc-N-bBWUdwiWdUqsJeI50/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9Nb2Rlcm5hX1Bob3RvXzEuSlBH.webp"/><…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data
    Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.
    STAT · 1mo ago↗ source
  • STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data
    Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.
    STAT · 1mo ago↗ source
  • New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises
    This week on "The Readout LOUD" podcast: new hope in treating Huntington's disease and a report card on RFK Jr.'s promises. Listen now.
    STAT · 1mo ago↗ source
  • Ebola cases increase almost 40% in a week as death toll passes 200
    Ebola cases have increased almost 40% in a week in the current outbreak in Congo and Uganda as the death toll passes 200.
    STAT · 1mo ago↗ source
  • cAMPfield lands $180M to build gut disease drug
    <figure><div><img src="https://imgproxy.divecdn.com/4eoVQHFTAvljHZA3dtwvKrrS1WlgcrV7_wLUFGcZYWw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjMwMTMxMDIyXzEua…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Do wearables actually help people with cardiovascular disease?
    In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.
    STAT · 1mo ago↗ source
  • STAT+: Cambrian’s experimental longevity drug mimics exercise
    What Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The Readout
    STAT · 1mo ago↗ source
  • Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
    <figure><div><img src="https://imgproxy.divecdn.com/Uto2VRn61o7u_sFbw6zPAlwZMdRxZOBYNj0bVh4-oRI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9nZW5fUGhvdG9fMy5KUEc=.webp"/><…
    BioPharma Dive · 1mo ago↗ source
  • Pfizer CFO to step down; Denali sells a regulatory fast-pass
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Shingles vaccine may lower dementia risk, new study finds
    Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
    Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer
    STAT · 1mo ago↗ source
  • How many Americans can afford high-quality health care? A new poll finds the number has fallen
    A new poll shows only about half of U.S. adults could afford their health care and had access to quality care last year.
    STAT · 1mo ago↗ source
  • Six of the biggest health news stories today
    High-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept
    A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do, STAT's Adam Feuerstein writes.
    STAT · 1mo ago↗ source
  • Super-potent synthetic opioids called nitazenes are spreading across the U.S.
    Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
    STAT · 1mo ago↗ source
  • Opinion: Congress should embrace strategic health diplomacy
    “Improving global health should be a top policy priority of the United States,” write Anand Parekh, Tom Daschle, and Bill Frist.
    STAT · 1mo ago↗ source
  • Opinion: AI’s growing appetite for power is a public health issue. Here’s a fix
    “AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J. Kissinger.
    STAT · 1mo ago↗ source